TACE With Immune Agents for Angiogenesis in Hepatocellular Carcinoma
Clinical trial NCT07053202 · COMPLETED
Trial details
- NCT number
- NCT07053202
- Sponsor
- The First Hospital of Hebei Medical University
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-01
- Primary completion
- 2022-11-01
- Enrollment
- 140
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.